Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 30, 2017 Filed Feb 1, 2017 00:58 UTC |
SALKA SUSAN RDirector · President and CEO
|
GrantCommon Stock | 80,477 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-006516 · doc4.xml · nonDerivative · entry 1 SALKA SUSAN R · CIK 0001158584 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 364,826 F1 · kind: The acquisition of Common Stock set forth in this row resulted from the deferred release of a Performance Restricted Stock Unit ("PRSU") award that vested on January 5, 2016. In 2013, the reporting person elected to defer receipt of these PRSUs pursuant to the Company's deferred compensation plan, with a settlement date of January 30, 2017. Read SEC document |
| January 06, 2017 Filed Jan 10, 2017 19:57 UTC |
Jackson Denise LGeneral Counsel / Sr. V.P.
|
SaleCommon Stock | 7,278 | $37.73 | $274,564.73 |
DisclosureSEC source: 0001209191-17-003119 · doc4.xml · nonDerivative · entry 2 Jackson Denise L · CIK 0001320242 · General Counsel / Sr. V.P. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,365 F3 · kind: The sale of 7,278 shares of Common Stock reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported in this row represents a weighted average price of $37.7253 per share. These shares were sold in multiple transactions at prices ranging from $37.725 to $37.75, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 06, 2017 Filed Jan 10, 2017 19:57 UTC |
Jackson Denise LGeneral Counsel / Sr. V.P.
|
SaleCommon Stock | 14,866 | $38.01 | $565,058.15 |
DisclosureSEC source: 0001209191-17-003119 · doc4.xml · nonDerivative · entry 1 Jackson Denise L · CIK 0001320242 · General Counsel / Sr. V.P. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,643 F1 · kind: The sale of 14,866 shares of Common Stock reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in this row represents a weighted average price of $38.0101 per share. These shares were sold in multiple transactions at prices ranging from $37.675 to $38.40, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 01:22 UTC |
SALKA SUSAN RDirector · President and CEO
|
GrantDeferred Performance Restricted Stock Units · Derivative | 42,096 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-002439 · doc4.xml · derivative · entry 1 SALKA SUSAN R · CIK 0001158584 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,096 Underlying: Common Stock · 42,096 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred Performance Restricted Stock Unit ("PRSU") represents a contingent right to receive one share of Common Stock. F2 · derivative.exercise_date: The deferred PRSUs in this row resulted from the vesting of a PRSU award granted by the Company on January 3, 2014. The ultimate number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of December 31, 2013 for the performance period beginning on January 1, 2014 and ended December 31, 2016 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on January 4, 2017. Based on the TSR Measurement, the maximum amount of PRSUs for the award were deemed earned and vested. In 2014, the reporting person elected to defer receipt of Common Stock underlying the deferred PRSUs set forth in this row until January 2, 2019. F3 · derivative.expiration_date: Deferred PRSUs do not have an expiration date. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 01:18 UTC |
Henderson RalphPres., Prof. Svc. & Staffing
|
GrantRestricted Stock Units · Derivative | 6,294 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-002434 · doc4.xml · derivative · entry 6 Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,294 Underlying: Common Stock · 6,294 shares Expires not disclosed F4 · derivative.exercise_price: The Restricted Stock Units were granted pursuant to the AMN Healthcare Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F7 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 4, 2017 and vest on the third anniversary of the grant date, provided, however, the Restricted Stock Units shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33%, should the Company achieve or exceed a certain specified earnings before interest, taxes, depreciation and amortization (EBITDA) target for the 2017 fiscal year and on the second anniversary of the grant date, in the amount of 34%, should the Company achieve or exceed the specified EBITDA target for the 2018 fiscal year. F6 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 01:18 UTC |
Henderson RalphPres., Prof. Svc. & Staffing
|
Tax withholdingCommon Stock | 4,704 | $38.93 | $183,103.20 |
DisclosureSEC source: 0001209191-17-002434 · doc4.xml · nonDerivative · entry 4 Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,521 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 01:18 UTC |
Henderson RalphPres., Prof. Svc. & Staffing
|
GrantCommon Stock | 12,553 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-002434 · doc4.xml · nonDerivative · entry 3 Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,225 F3 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 3, 2014. The ultimate number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of December 31, 2013 for the 3-year period beginning on January 1, 2014 and ended December 31, 2016 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on January 4, 2017. The Company's Relative TSR measured in the 97th percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award were deemed earned and vested. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 01:17 UTC |
Jackson Denise LGeneral Counsel / Sr. V.P.
|
GrantRestricted Stock Units · Derivative | 3,687 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-002431 · doc4.xml · derivative · entry 9 Jackson Denise L · CIK 0001320242 · General Counsel / Sr. V.P. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,687 Underlying: Common Stock · 3,687 shares Expires not disclosed F4 · derivative.exercise_price: The Restricted Stock Units were granted pursuant to the AMN Healthcare Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F7 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 4, 2017 and vest on the third anniversary of the grant date, provided, however, the Restricted Stock Units shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33%, should the Company achieve or exceed a certain specified earnings before interest, taxes, depreciation and amortization (EBITDA) target for the 2017 fiscal year and on the second anniversary of the grant date, in the amount of 34%, should the Company achieve or exceed the specified EBITDA target for the 2018 fiscal year. F6 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 01:17 UTC |
Jackson Denise LGeneral Counsel / Sr. V.P.
|
Tax withholdingCommon Stock | 4,356 | $38.93 | $169,557.30 |
DisclosureSEC source: 0001209191-17-002431 · doc4.xml · nonDerivative · entry 7 Jackson Denise L · CIK 0001320242 · General Counsel / Sr. V.P. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,509 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 01:17 UTC |
Jackson Denise LGeneral Counsel / Sr. V.P.
|
GrantCommon Stock | 11,634 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-002431 · doc4.xml · nonDerivative · entry 6 Jackson Denise L · CIK 0001320242 · General Counsel / Sr. V.P. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,865 F3 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 3, 2014. The ultimate number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of December 31, 2013 for the 3-year period beginning on January 1, 2014 and ended December 31, 2016 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on January 4, 2017. The Company's Relative TSR measured in the 97th percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award were deemed earned and vested. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 01:13 UTC |
Scott Brian M.CFO/CAO
|
GrantRestricted Stock Units · Derivative | 6,294 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-002428 · doc4.xml · derivative · entry 6 Scott Brian M. · CIK 0001510242 · CFO/CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,294 Underlying: Common Stock · 6,294 shares Expires not disclosed F4 · derivative.exercise_price: The Restricted Stock Units were granted pursuant to the AMN Healthcare Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F7 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 4, 2017 and vest on the third anniversary of the grant date, provided, however, the Restricted Stock Units shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33%, should the Company achieve or exceed a certain specified earnings before interest, taxes, depreciation and amortization (EBITDA) target for the 2017 fiscal year and on the second anniversary of the grant date, in the amount of 34%, should the Company achieve or exceed the specified EBITDA target for the 2018 fiscal year. F6 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 01:13 UTC |
Scott Brian M.CFO/CAO
|
Tax withholdingCommon Stock | 4,588 | $38.93 | $178,587.90 |
DisclosureSEC source: 0001209191-17-002428 · doc4.xml · nonDerivative · entry 4 Scott Brian M. · CIK 0001510242 · CFO/CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,148 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 01:13 UTC |
Scott Brian M.CFO/CAO
|
GrantCommon Stock | 12,247 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-002428 · doc4.xml · nonDerivative · entry 3 Scott Brian M. · CIK 0001510242 · CFO/CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,736 F3 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 3, 2014. The ultimate number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of December 31, 2013 for the 3-year period beginning on January 1, 2014 and ended December 31, 2016 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on January 4, 2017. The Company's Relative TSR measured in the 97th percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award were deemed earned and vested. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 01:18 UTC |
Henderson RalphPres., Prof. Svc. & Staffing
|
Exercise / conversionRestricted Stock Units · Derivative | 3,314 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-002434 · doc4.xml · derivative · entry 5 Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,314 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The Restricted Stock Units were granted pursuant to the AMN Healthcare Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units were granted on January 3, 2014 and vest on the third anniversary of the grant date. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F6 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 01:18 UTC |
Henderson RalphPres., Prof. Svc. & Staffing
|
Tax withholdingCommon Stock | 1,414 | $38.50 | $54,439.00 |
DisclosureSEC source: 0001209191-17-002434 · doc4.xml · nonDerivative · entry 2 Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,672 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 01:18 UTC |
Henderson RalphPres., Prof. Svc. & Staffing
|
Exercise / conversionCommon Stock | 3,314 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-002434 · doc4.xml · nonDerivative · entry 1 Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,086 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 01:17 UTC |
Jackson Denise LGeneral Counsel / Sr. V.P.
|
Exercise / conversionRestricted Stock Units · Derivative | 3,071 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-002431 · doc4.xml · derivative · entry 8 Jackson Denise L · CIK 0001320242 · General Counsel / Sr. V.P. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,071 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The Restricted Stock Units were granted pursuant to the AMN Healthcare Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units were granted on January 3, 2014 and vest on the third anniversary of the grant date. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F6 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 01:17 UTC |
Jackson Denise LGeneral Counsel / Sr. V.P.
|
Tax withholdingCommon Stock | 1,330 | $38.50 | $51,205.00 |
DisclosureSEC source: 0001209191-17-002431 · doc4.xml · nonDerivative · entry 5 Jackson Denise L · CIK 0001320242 · General Counsel / Sr. V.P. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,231 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 01:17 UTC |
Jackson Denise LGeneral Counsel / Sr. V.P.
|
Exercise / conversionCommon Stock | 3,071 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-002431 · doc4.xml · nonDerivative · entry 4 Jackson Denise L · CIK 0001320242 · General Counsel / Sr. V.P. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,561 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 01:13 UTC |
Scott Brian M.CFO/CAO
|
Exercise / conversionRestricted Stock Units · Derivative | 3,233 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-002428 · doc4.xml · derivative · entry 5 Scott Brian M. · CIK 0001510242 · CFO/CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,233 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The Restricted Stock Units were granted pursuant to the AMN Healthcare Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units were granted on January 3, 2014 and vest on the third anniversary of the grant date. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F6 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 01:13 UTC |
Scott Brian M.CFO/CAO
|
Tax withholdingCommon Stock | 1,384 | $38.50 | $53,284.00 |
DisclosureSEC source: 0001209191-17-002428 · doc4.xml · nonDerivative · entry 2 Scott Brian M. · CIK 0001510242 · CFO/CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,489 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 01:13 UTC |
Scott Brian M.CFO/CAO
|
Exercise / conversionCommon Stock | 3,233 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-002428 · doc4.xml · nonDerivative · entry 1 Scott Brian M. · CIK 0001510242 · CFO/CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,873 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units. Read SEC document |
| December 16, 2016 Filed Jan 6, 2017 01:17 UTC |
Jackson Denise LGeneral Counsel / Sr. V.P.
|
GiftCommon Stock | 3,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-002431 · doc4.xml · nonDerivative · entry 3 Jackson Denise L · CIK 0001320242 · General Counsel / Sr. V.P. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,490 Read SEC document |
| December 15, 2016 Filed Dec 16, 2016 23:27 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 1,800 | $37.81 | $68,058.00 |
DisclosureSEC source: 0001209191-16-155714 · doc4.xml · nonDerivative · entry 1 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,732 F1 · price: The price reported in this row represents a weighted average price of $37.81 per share. These shares were sold in multiple transactions at prices ranging from $37.805 to $37.83, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 14, 2016 Filed Dec 16, 2016 01:07 UTC |
Scott Brian M.CFO/CAO
|
SaleCommon Stock | 2,008 | $40.02 | $80,364.98 |
DisclosureSEC source: 0001209191-16-155514 · doc4.xml · nonDerivative · entry 1 Scott Brian M. · CIK 0001510242 · CFO/CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,640 F1 · kind: The sale of 2,008 shares of Common Stock set forth in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in this row represents a weighted average price of $40.0224 per share. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.10, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 12, 2016 Filed Dec 14, 2016 00:05 UTC |
SALKA SUSAN RDirector · President and CEO
|
GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-155025 · doc4.xml · nonDerivative · entry 3 SALKA SUSAN R · CIK 0001158584 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,349 F3 · kind: The reporting person transferred 10,000 shares of AMN Common Stock as a gift to charity. Read SEC document |
| December 09, 2016 Filed Dec 14, 2016 00:05 UTC |
SALKA SUSAN RDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 11,837 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-155025 · doc4.xml · derivative · entry 4 SALKA SUSAN R · CIK 0001158584 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,837 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units were granted on December 9, 2013 and vest on the third anniversary of the grant date. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F6 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| December 09, 2016 Filed Dec 14, 2016 00:05 UTC |
SALKA SUSAN RDirector · President and CEO
|
Tax withholdingCommon Stock | 6,176 | $36.35 | $224,497.60 |
DisclosureSEC source: 0001209191-16-155025 · doc4.xml · nonDerivative · entry 2 SALKA SUSAN R · CIK 0001158584 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 294,349 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| December 09, 2016 Filed Dec 14, 2016 00:05 UTC |
SALKA SUSAN RDirector · President and CEO
|
Exercise / conversionCommon Stock | 11,837 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-155025 · doc4.xml · nonDerivative · entry 1 SALKA SUSAN R · CIK 0001158584 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,525 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units. Read SEC document |
| December 05, 2016 Filed Dec 7, 2016 22:19 UTC |
SALKA SUSAN RDirector · President and CEO
|
GrantRestricted Stock Units · Derivative | 29,917 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-153949 · doc4.xml · derivative · entry 1 SALKA SUSAN R · CIK 0001158584 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,917 Underlying: Common Stock · 29,917 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units were granted pursuant to the AMN Healthcare Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units were granted on December 5, 2016 and vest on the third anniversary of the grant date, provided, however, the Restricted Stock Units shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33% should the Company achieve or exceed a certain specified earnings before interest, taxes, depreciation and amortization (EBITDA) target for the 2017 fiscal year, and on the second anniversary of the grant date in the amount of 34% should the Company achieve or exceed the specified EBITDA target for the 2018 fiscal year. F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| November 16, 2016 Filed Jan 6, 2017 01:17 UTC |
Jackson Denise LGeneral Counsel / Sr. V.P.
|
GiftCommon Stock | 162 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-002431 · doc4.xml · nonDerivative · entry 2 Jackson Denise L · CIK 0001320242 · General Counsel / Sr. V.P. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,340 Read SEC document |
| May 12, 2016 Filed Jan 6, 2017 01:17 UTC |
Jackson Denise LGeneral Counsel / Sr. V.P.
|
GiftCommon Stock | 275 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-002431 · doc4.xml · nonDerivative · entry 1 Jackson Denise L · CIK 0001320242 · General Counsel / Sr. V.P. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,502 Read SEC document |
| August 09, 2012 Filed Oct 15, 2012 23:04 UTC |
GOLDMAN SACHS GROUP INC10% owner
GOLDMAN SACHS & CO. LLC10% owner
GSUIG, L.L.C.10% owner
|
SaleCommon Stock | 143,422 | $6.42 | $920,826.61 |
DisclosureSEC source: 0000769993-12-000566 · ownershipdoc09062012120835.xml · nonDerivative · entry 28 GOLDMAN SACHS GROUP INC · CIK 0000886982 · 10% owner GOLDMAN SACHS & CO · CIK 0000769993 · 10% owner GSUIG, L.L.C. · CIK 0001472042 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 872,908 F32 · price: Reflects a weighted average sale price of $6.4204 per share, at prices ranging from $6.24 to $6.51 per share. F33 · price: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. F1 · ownership.nature: This statement is being filed by The Goldman Sachs Group, Inc. ("GS Group"), Goldman, Sachs & Co. ("Goldman Sachs") and GSUIG, L.L.C. ("GSUIG", and together with GS Group and Goldman Sachs, the "Reporting Persons"). Goldman Sachs is a wholly-owned subsidiary of GS Group. GS Group is the sole member of GSUIG and Goldman Sachs serves as the investment manager for GSUIG. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein. F3 · ownership.nature: The shares of common stock, par value $0.01 per share (the "Common Stock") of AMN Healthcare Services, Inc. (the "Company") reported herein as indirectly purchased and sold were beneficially owned directly by Goldman Sachs or GSUIG, and indirectly by GS Group. F4 · ownership.nature: As of August 9, 2012, Goldman Sachs beneficially owns directly, and GS Group may be deemed to beneficially own indirectly, 56,156 shares of Common Stock and Goldman Sachs also holds open short positions of 317,345 shares of Common Stock, reflecting changes due to exempt transactions. As of August 9, 2012, Goldman Sachs and GS Group may be deemed to beneficially own indirectly 812,175 shares of Common Stock by reason of the direct beneficial ownership of such shares by GSUIG. GS Group also beneficially owns directly 4,577 shares of Common Stock. F32 · ownership.nature: Reflects a weighted average sale price of $6.4204 per share, at prices ranging from $6.24 to $6.51 per share. F33 · ownership.nature: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| August 08, 2012 Filed Oct 15, 2012 23:04 UTC |
GOLDMAN SACHS GROUP INC10% owner
GOLDMAN SACHS & CO. LLC10% owner
GSUIG, L.L.C.10% owner
|
SaleCommon Stock | 52,590 | $6.14 | $322,639.65 |
DisclosureSEC source: 0000769993-12-000566 · ownershipdoc09062012120835.xml · nonDerivative · entry 27 GOLDMAN SACHS GROUP INC · CIK 0000886982 · 10% owner GOLDMAN SACHS & CO · CIK 0000769993 · 10% owner GSUIG, L.L.C. · CIK 0001472042 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,051,885 F31 · price: Reflects a weighted average sale price of $6.135 per share, at prices ranging from $6.05 to $6.17 per share. F33 · price: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. F1 · ownership.nature: This statement is being filed by The Goldman Sachs Group, Inc. ("GS Group"), Goldman, Sachs & Co. ("Goldman Sachs") and GSUIG, L.L.C. ("GSUIG", and together with GS Group and Goldman Sachs, the "Reporting Persons"). Goldman Sachs is a wholly-owned subsidiary of GS Group. GS Group is the sole member of GSUIG and Goldman Sachs serves as the investment manager for GSUIG. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein. F2 · ownership.nature: Due to an inadvertent error that resulted in the Common Stock underlying the shares of convertible preferred stock of the Company held in escrow being excluded from the beneficial ownership of the Reporting Persons under Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder ("Section 13(d)"), the Reporting Persons ceased to be greater than 10% beneficial owners under Section 13(d) on August 9, 2012 (the "10% Cessation Date"), and not on June 19, 2012 as previously reported. This Form 4 filing reports transactions executed up to and including the 10% Cessation Date. The Reporting Persons have remitted to the Issuer any profits, accordingly. F3 · ownership.nature: The shares of common stock, par value $0.01 per share (the "Common Stock") of AMN Healthcare Services, Inc. (the "Company") reported herein as indirectly purchased and sold were beneficially owned directly by Goldman Sachs or GSUIG, and indirectly by GS Group. F4 · ownership.nature: As of August 9, 2012, Goldman Sachs beneficially owns directly, and GS Group may be deemed to beneficially own indirectly, 56,156 shares of Common Stock and Goldman Sachs also holds open short positions of 317,345 shares of Common Stock, reflecting changes due to exempt transactions. As of August 9, 2012, Goldman Sachs and GS Group may be deemed to beneficially own indirectly 812,175 shares of Common Stock by reason of the direct beneficial ownership of such shares by GSUIG. GS Group also beneficially owns directly 4,577 shares of Common Stock. F31 · ownership.nature: Reflects a weighted average sale price of $6.135 per share, at prices ranging from $6.05 to $6.17 per share. F33 · ownership.nature: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| August 07, 2012 Filed Oct 15, 2012 23:04 UTC |
GOLDMAN SACHS GROUP INC10% owner
GOLDMAN SACHS & CO. LLC10% owner
GSUIG, L.L.C.10% owner
|
SaleCommon Stock | 50,193 | $6.06 | $304,069.19 |
DisclosureSEC source: 0000769993-12-000566 · ownershipdoc09062012120835.xml · nonDerivative · entry 26 GOLDMAN SACHS GROUP INC · CIK 0000886982 · 10% owner GOLDMAN SACHS & CO · CIK 0000769993 · 10% owner GSUIG, L.L.C. · CIK 0001472042 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,104,475 F30 · price: Reflects a weighted average sale price of $6.058 per share, at prices ranging from $6.01 to $6.09 per share. F33 · price: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. F1 · ownership.nature: This statement is being filed by The Goldman Sachs Group, Inc. ("GS Group"), Goldman, Sachs & Co. ("Goldman Sachs") and GSUIG, L.L.C. ("GSUIG", and together with GS Group and Goldman Sachs, the "Reporting Persons"). Goldman Sachs is a wholly-owned subsidiary of GS Group. GS Group is the sole member of GSUIG and Goldman Sachs serves as the investment manager for GSUIG. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein. F2 · ownership.nature: Due to an inadvertent error that resulted in the Common Stock underlying the shares of convertible preferred stock of the Company held in escrow being excluded from the beneficial ownership of the Reporting Persons under Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder ("Section 13(d)"), the Reporting Persons ceased to be greater than 10% beneficial owners under Section 13(d) on August 9, 2012 (the "10% Cessation Date"), and not on June 19, 2012 as previously reported. This Form 4 filing reports transactions executed up to and including the 10% Cessation Date. The Reporting Persons have remitted to the Issuer any profits, accordingly. F3 · ownership.nature: The shares of common stock, par value $0.01 per share (the "Common Stock") of AMN Healthcare Services, Inc. (the "Company") reported herein as indirectly purchased and sold were beneficially owned directly by Goldman Sachs or GSUIG, and indirectly by GS Group. F4 · ownership.nature: As of August 9, 2012, Goldman Sachs beneficially owns directly, and GS Group may be deemed to beneficially own indirectly, 56,156 shares of Common Stock and Goldman Sachs also holds open short positions of 317,345 shares of Common Stock, reflecting changes due to exempt transactions. As of August 9, 2012, Goldman Sachs and GS Group may be deemed to beneficially own indirectly 812,175 shares of Common Stock by reason of the direct beneficial ownership of such shares by GSUIG. GS Group also beneficially owns directly 4,577 shares of Common Stock. F30 · ownership.nature: Reflects a weighted average sale price of $6.058 per share, at prices ranging from $6.01 to $6.09 per share. F33 · ownership.nature: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| August 07, 2012 Filed Oct 15, 2012 23:04 UTC |
GOLDMAN SACHS GROUP INC10% owner
GOLDMAN SACHS & CO. LLC10% owner
GSUIG, L.L.C.10% owner
|
PurchaseCommon Stock | 1,000 | $6.06 | $6,062.00 |
DisclosureSEC source: 0000769993-12-000566 · ownershipdoc09062012120835.xml · nonDerivative · entry 25 GOLDMAN SACHS GROUP INC · CIK 0000886982 · 10% owner GOLDMAN SACHS & CO · CIK 0000769993 · 10% owner GSUIG, L.L.C. · CIK 0001472042 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,154,668 F29 · price: Reflects a weighted average purchase price of $6.062 per share, at prices ranging from $6.04 to $6.07 per share. F33 · price: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. F1 · ownership.nature: This statement is being filed by The Goldman Sachs Group, Inc. ("GS Group"), Goldman, Sachs & Co. ("Goldman Sachs") and GSUIG, L.L.C. ("GSUIG", and together with GS Group and Goldman Sachs, the "Reporting Persons"). Goldman Sachs is a wholly-owned subsidiary of GS Group. GS Group is the sole member of GSUIG and Goldman Sachs serves as the investment manager for GSUIG. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein. F2 · ownership.nature: Due to an inadvertent error that resulted in the Common Stock underlying the shares of convertible preferred stock of the Company held in escrow being excluded from the beneficial ownership of the Reporting Persons under Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder ("Section 13(d)"), the Reporting Persons ceased to be greater than 10% beneficial owners under Section 13(d) on August 9, 2012 (the "10% Cessation Date"), and not on June 19, 2012 as previously reported. This Form 4 filing reports transactions executed up to and including the 10% Cessation Date. The Reporting Persons have remitted to the Issuer any profits, accordingly. F3 · ownership.nature: The shares of common stock, par value $0.01 per share (the "Common Stock") of AMN Healthcare Services, Inc. (the "Company") reported herein as indirectly purchased and sold were beneficially owned directly by Goldman Sachs or GSUIG, and indirectly by GS Group. F4 · ownership.nature: As of August 9, 2012, Goldman Sachs beneficially owns directly, and GS Group may be deemed to beneficially own indirectly, 56,156 shares of Common Stock and Goldman Sachs also holds open short positions of 317,345 shares of Common Stock, reflecting changes due to exempt transactions. As of August 9, 2012, Goldman Sachs and GS Group may be deemed to beneficially own indirectly 812,175 shares of Common Stock by reason of the direct beneficial ownership of such shares by GSUIG. GS Group also beneficially owns directly 4,577 shares of Common Stock. F29 · ownership.nature: Reflects a weighted average purchase price of $6.062 per share, at prices ranging from $6.04 to $6.07 per share. F33 · ownership.nature: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| August 06, 2012 Filed Oct 15, 2012 23:04 UTC |
GOLDMAN SACHS GROUP INC10% owner
GOLDMAN SACHS & CO. LLC10% owner
GSUIG, L.L.C.10% owner
|
SaleCommon Stock | 69,847 | $6.09 | $425,081.86 |
DisclosureSEC source: 0000769993-12-000566 · ownershipdoc09062012120835.xml · nonDerivative · entry 24 GOLDMAN SACHS GROUP INC · CIK 0000886982 · 10% owner GOLDMAN SACHS & CO · CIK 0000769993 · 10% owner GSUIG, L.L.C. · CIK 0001472042 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,153,668 F28 · price: Reflects a weighted average sale price of $6.0859 per share, at prices ranging from $6.00 to $6.15 per share. F33 · price: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. F1 · ownership.nature: This statement is being filed by The Goldman Sachs Group, Inc. ("GS Group"), Goldman, Sachs & Co. ("Goldman Sachs") and GSUIG, L.L.C. ("GSUIG", and together with GS Group and Goldman Sachs, the "Reporting Persons"). Goldman Sachs is a wholly-owned subsidiary of GS Group. GS Group is the sole member of GSUIG and Goldman Sachs serves as the investment manager for GSUIG. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein. F2 · ownership.nature: Due to an inadvertent error that resulted in the Common Stock underlying the shares of convertible preferred stock of the Company held in escrow being excluded from the beneficial ownership of the Reporting Persons under Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder ("Section 13(d)"), the Reporting Persons ceased to be greater than 10% beneficial owners under Section 13(d) on August 9, 2012 (the "10% Cessation Date"), and not on June 19, 2012 as previously reported. This Form 4 filing reports transactions executed up to and including the 10% Cessation Date. The Reporting Persons have remitted to the Issuer any profits, accordingly. F3 · ownership.nature: The shares of common stock, par value $0.01 per share (the "Common Stock") of AMN Healthcare Services, Inc. (the "Company") reported herein as indirectly purchased and sold were beneficially owned directly by Goldman Sachs or GSUIG, and indirectly by GS Group. F4 · ownership.nature: As of August 9, 2012, Goldman Sachs beneficially owns directly, and GS Group may be deemed to beneficially own indirectly, 56,156 shares of Common Stock and Goldman Sachs also holds open short positions of 317,345 shares of Common Stock, reflecting changes due to exempt transactions. As of August 9, 2012, Goldman Sachs and GS Group may be deemed to beneficially own indirectly 812,175 shares of Common Stock by reason of the direct beneficial ownership of such shares by GSUIG. GS Group also beneficially owns directly 4,577 shares of Common Stock. F28 · ownership.nature: Reflects a weighted average sale price of $6.0859 per share, at prices ranging from $6.00 to $6.15 per share. F33 · ownership.nature: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| August 06, 2012 Filed Oct 15, 2012 23:04 UTC |
GOLDMAN SACHS GROUP INC10% owner
GOLDMAN SACHS & CO. LLC10% owner
GSUIG, L.L.C.10% owner
|
PurchaseCommon Stock | 23,601 | $6.09 | $143,616.81 |
DisclosureSEC source: 0000769993-12-000566 · ownershipdoc09062012120835.xml · nonDerivative · entry 23 GOLDMAN SACHS GROUP INC · CIK 0000886982 · 10% owner GOLDMAN SACHS & CO · CIK 0000769993 · 10% owner GSUIG, L.L.C. · CIK 0001472042 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,223,515 F27 · price: Reflects a weighted average purchase price of $6.0852 per share, at prices ranging from $5.99 to $6.145 per share. F33 · price: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. F1 · ownership.nature: This statement is being filed by The Goldman Sachs Group, Inc. ("GS Group"), Goldman, Sachs & Co. ("Goldman Sachs") and GSUIG, L.L.C. ("GSUIG", and together with GS Group and Goldman Sachs, the "Reporting Persons"). Goldman Sachs is a wholly-owned subsidiary of GS Group. GS Group is the sole member of GSUIG and Goldman Sachs serves as the investment manager for GSUIG. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein. F2 · ownership.nature: Due to an inadvertent error that resulted in the Common Stock underlying the shares of convertible preferred stock of the Company held in escrow being excluded from the beneficial ownership of the Reporting Persons under Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder ("Section 13(d)"), the Reporting Persons ceased to be greater than 10% beneficial owners under Section 13(d) on August 9, 2012 (the "10% Cessation Date"), and not on June 19, 2012 as previously reported. This Form 4 filing reports transactions executed up to and including the 10% Cessation Date. The Reporting Persons have remitted to the Issuer any profits, accordingly. F3 · ownership.nature: The shares of common stock, par value $0.01 per share (the "Common Stock") of AMN Healthcare Services, Inc. (the "Company") reported herein as indirectly purchased and sold were beneficially owned directly by Goldman Sachs or GSUIG, and indirectly by GS Group. F4 · ownership.nature: As of August 9, 2012, Goldman Sachs beneficially owns directly, and GS Group may be deemed to beneficially own indirectly, 56,156 shares of Common Stock and Goldman Sachs also holds open short positions of 317,345 shares of Common Stock, reflecting changes due to exempt transactions. As of August 9, 2012, Goldman Sachs and GS Group may be deemed to beneficially own indirectly 812,175 shares of Common Stock by reason of the direct beneficial ownership of such shares by GSUIG. GS Group also beneficially owns directly 4,577 shares of Common Stock. F27 · ownership.nature: Reflects a weighted average purchase price of $6.0852 per share, at prices ranging from $5.99 to $6.145 per share. F33 · ownership.nature: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| August 03, 2012 Filed Oct 15, 2012 23:04 UTC |
GOLDMAN SACHS GROUP INC10% owner
GOLDMAN SACHS & CO. LLC10% owner
GSUIG, L.L.C.10% owner
|
SaleCommon Stock | 137,716 | $6.12 | $842,339.91 |
DisclosureSEC source: 0000769993-12-000566 · ownershipdoc09062012120835.xml · nonDerivative · entry 22 GOLDMAN SACHS GROUP INC · CIK 0000886982 · 10% owner GOLDMAN SACHS & CO · CIK 0000769993 · 10% owner GSUIG, L.L.C. · CIK 0001472042 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,199,914 F26 · price: Reflects a weighted average sale price of $6.1165 per share, at prices ranging from $6.00 to $6.35 per share. F33 · price: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. F1 · ownership.nature: This statement is being filed by The Goldman Sachs Group, Inc. ("GS Group"), Goldman, Sachs & Co. ("Goldman Sachs") and GSUIG, L.L.C. ("GSUIG", and together with GS Group and Goldman Sachs, the "Reporting Persons"). Goldman Sachs is a wholly-owned subsidiary of GS Group. GS Group is the sole member of GSUIG and Goldman Sachs serves as the investment manager for GSUIG. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein. F2 · ownership.nature: Due to an inadvertent error that resulted in the Common Stock underlying the shares of convertible preferred stock of the Company held in escrow being excluded from the beneficial ownership of the Reporting Persons under Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder ("Section 13(d)"), the Reporting Persons ceased to be greater than 10% beneficial owners under Section 13(d) on August 9, 2012 (the "10% Cessation Date"), and not on June 19, 2012 as previously reported. This Form 4 filing reports transactions executed up to and including the 10% Cessation Date. The Reporting Persons have remitted to the Issuer any profits, accordingly. F3 · ownership.nature: The shares of common stock, par value $0.01 per share (the "Common Stock") of AMN Healthcare Services, Inc. (the "Company") reported herein as indirectly purchased and sold were beneficially owned directly by Goldman Sachs or GSUIG, and indirectly by GS Group. F4 · ownership.nature: As of August 9, 2012, Goldman Sachs beneficially owns directly, and GS Group may be deemed to beneficially own indirectly, 56,156 shares of Common Stock and Goldman Sachs also holds open short positions of 317,345 shares of Common Stock, reflecting changes due to exempt transactions. As of August 9, 2012, Goldman Sachs and GS Group may be deemed to beneficially own indirectly 812,175 shares of Common Stock by reason of the direct beneficial ownership of such shares by GSUIG. GS Group also beneficially owns directly 4,577 shares of Common Stock. F26 · ownership.nature: Reflects a weighted average sale price of $6.1165 per share, at prices ranging from $6.00 to $6.35 per share. F33 · ownership.nature: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| August 03, 2012 Filed Oct 15, 2012 23:04 UTC |
GOLDMAN SACHS GROUP INC10% owner
GOLDMAN SACHS & CO. LLC10% owner
GSUIG, L.L.C.10% owner
|
PurchaseCommon Stock | 39,065 | $6.15 | $240,144.27 |
DisclosureSEC source: 0000769993-12-000566 · ownershipdoc09062012120835.xml · nonDerivative · entry 21 GOLDMAN SACHS GROUP INC · CIK 0000886982 · 10% owner GOLDMAN SACHS & CO · CIK 0000769993 · 10% owner GSUIG, L.L.C. · CIK 0001472042 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,337,630 F25 · price: Reflects a weighted average purchase price of $6.1473 per share, at prices ranging from $5.99 to $6.28 per share. F33 · price: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. F1 · ownership.nature: This statement is being filed by The Goldman Sachs Group, Inc. ("GS Group"), Goldman, Sachs & Co. ("Goldman Sachs") and GSUIG, L.L.C. ("GSUIG", and together with GS Group and Goldman Sachs, the "Reporting Persons"). Goldman Sachs is a wholly-owned subsidiary of GS Group. GS Group is the sole member of GSUIG and Goldman Sachs serves as the investment manager for GSUIG. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein. F2 · ownership.nature: Due to an inadvertent error that resulted in the Common Stock underlying the shares of convertible preferred stock of the Company held in escrow being excluded from the beneficial ownership of the Reporting Persons under Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder ("Section 13(d)"), the Reporting Persons ceased to be greater than 10% beneficial owners under Section 13(d) on August 9, 2012 (the "10% Cessation Date"), and not on June 19, 2012 as previously reported. This Form 4 filing reports transactions executed up to and including the 10% Cessation Date. The Reporting Persons have remitted to the Issuer any profits, accordingly. F3 · ownership.nature: The shares of common stock, par value $0.01 per share (the "Common Stock") of AMN Healthcare Services, Inc. (the "Company") reported herein as indirectly purchased and sold were beneficially owned directly by Goldman Sachs or GSUIG, and indirectly by GS Group. F4 · ownership.nature: As of August 9, 2012, Goldman Sachs beneficially owns directly, and GS Group may be deemed to beneficially own indirectly, 56,156 shares of Common Stock and Goldman Sachs also holds open short positions of 317,345 shares of Common Stock, reflecting changes due to exempt transactions. As of August 9, 2012, Goldman Sachs and GS Group may be deemed to beneficially own indirectly 812,175 shares of Common Stock by reason of the direct beneficial ownership of such shares by GSUIG. GS Group also beneficially owns directly 4,577 shares of Common Stock. F25 · ownership.nature: Reflects a weighted average purchase price of $6.1473 per share, at prices ranging from $5.99 to $6.28 per share. F33 · ownership.nature: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| August 02, 2012 Filed Oct 15, 2012 23:04 UTC |
GOLDMAN SACHS GROUP INC10% owner
GOLDMAN SACHS & CO. LLC10% owner
GSUIG, L.L.C.10% owner
|
SaleCommon Stock | 6,016 | $5.57 | $33,511.53 |
DisclosureSEC source: 0000769993-12-000566 · ownershipdoc09062012120835.xml · nonDerivative · entry 20 GOLDMAN SACHS GROUP INC · CIK 0000886982 · 10% owner GOLDMAN SACHS & CO · CIK 0000769993 · 10% owner GSUIG, L.L.C. · CIK 0001472042 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,298,565 F24 · price: Reflects a weighted average sale price of $5.5704 per share, at prices ranging from $5.505 to $5.67 per share. F33 · price: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. F1 · ownership.nature: This statement is being filed by The Goldman Sachs Group, Inc. ("GS Group"), Goldman, Sachs & Co. ("Goldman Sachs") and GSUIG, L.L.C. ("GSUIG", and together with GS Group and Goldman Sachs, the "Reporting Persons"). Goldman Sachs is a wholly-owned subsidiary of GS Group. GS Group is the sole member of GSUIG and Goldman Sachs serves as the investment manager for GSUIG. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein. F2 · ownership.nature: Due to an inadvertent error that resulted in the Common Stock underlying the shares of convertible preferred stock of the Company held in escrow being excluded from the beneficial ownership of the Reporting Persons under Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder ("Section 13(d)"), the Reporting Persons ceased to be greater than 10% beneficial owners under Section 13(d) on August 9, 2012 (the "10% Cessation Date"), and not on June 19, 2012 as previously reported. This Form 4 filing reports transactions executed up to and including the 10% Cessation Date. The Reporting Persons have remitted to the Issuer any profits, accordingly. F3 · ownership.nature: The shares of common stock, par value $0.01 per share (the "Common Stock") of AMN Healthcare Services, Inc. (the "Company") reported herein as indirectly purchased and sold were beneficially owned directly by Goldman Sachs or GSUIG, and indirectly by GS Group. F4 · ownership.nature: As of August 9, 2012, Goldman Sachs beneficially owns directly, and GS Group may be deemed to beneficially own indirectly, 56,156 shares of Common Stock and Goldman Sachs also holds open short positions of 317,345 shares of Common Stock, reflecting changes due to exempt transactions. As of August 9, 2012, Goldman Sachs and GS Group may be deemed to beneficially own indirectly 812,175 shares of Common Stock by reason of the direct beneficial ownership of such shares by GSUIG. GS Group also beneficially owns directly 4,577 shares of Common Stock. F24 · ownership.nature: Reflects a weighted average sale price of $5.5704 per share, at prices ranging from $5.505 to $5.67 per share. F33 · ownership.nature: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| August 01, 2012 Filed Oct 15, 2012 23:04 UTC |
GOLDMAN SACHS GROUP INC10% owner
GOLDMAN SACHS & CO. LLC10% owner
GSUIG, L.L.C.10% owner
|
SaleCommon Stock | 10,835 | $5.77 | $62,529.87 |
DisclosureSEC source: 0000769993-12-000566 · ownershipdoc09062012120835.xml · nonDerivative · entry 19 GOLDMAN SACHS GROUP INC · CIK 0000886982 · 10% owner GOLDMAN SACHS & CO · CIK 0000769993 · 10% owner GSUIG, L.L.C. · CIK 0001472042 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,304,581 F23 · price: Reflects a weighted average sale price of $5.7711 per share, at prices ranging from $5.75 to $5.86 per share. F33 · price: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. F1 · ownership.nature: This statement is being filed by The Goldman Sachs Group, Inc. ("GS Group"), Goldman, Sachs & Co. ("Goldman Sachs") and GSUIG, L.L.C. ("GSUIG", and together with GS Group and Goldman Sachs, the "Reporting Persons"). Goldman Sachs is a wholly-owned subsidiary of GS Group. GS Group is the sole member of GSUIG and Goldman Sachs serves as the investment manager for GSUIG. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein. F2 · ownership.nature: Due to an inadvertent error that resulted in the Common Stock underlying the shares of convertible preferred stock of the Company held in escrow being excluded from the beneficial ownership of the Reporting Persons under Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder ("Section 13(d)"), the Reporting Persons ceased to be greater than 10% beneficial owners under Section 13(d) on August 9, 2012 (the "10% Cessation Date"), and not on June 19, 2012 as previously reported. This Form 4 filing reports transactions executed up to and including the 10% Cessation Date. The Reporting Persons have remitted to the Issuer any profits, accordingly. F3 · ownership.nature: The shares of common stock, par value $0.01 per share (the "Common Stock") of AMN Healthcare Services, Inc. (the "Company") reported herein as indirectly purchased and sold were beneficially owned directly by Goldman Sachs or GSUIG, and indirectly by GS Group. F4 · ownership.nature: As of August 9, 2012, Goldman Sachs beneficially owns directly, and GS Group may be deemed to beneficially own indirectly, 56,156 shares of Common Stock and Goldman Sachs also holds open short positions of 317,345 shares of Common Stock, reflecting changes due to exempt transactions. As of August 9, 2012, Goldman Sachs and GS Group may be deemed to beneficially own indirectly 812,175 shares of Common Stock by reason of the direct beneficial ownership of such shares by GSUIG. GS Group also beneficially owns directly 4,577 shares of Common Stock. F23 · ownership.nature: Reflects a weighted average sale price of $5.7711 per share, at prices ranging from $5.75 to $5.86 per share. F33 · ownership.nature: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| August 01, 2012 Filed Oct 15, 2012 23:04 UTC |
GOLDMAN SACHS GROUP INC10% owner
GOLDMAN SACHS & CO. LLC10% owner
GSUIG, L.L.C.10% owner
|
PurchaseCommon Stock | 930 | $5.76 | $5,352.62 |
DisclosureSEC source: 0000769993-12-000566 · ownershipdoc09062012120835.xml · nonDerivative · entry 18 GOLDMAN SACHS GROUP INC · CIK 0000886982 · 10% owner GOLDMAN SACHS & CO · CIK 0000769993 · 10% owner GSUIG, L.L.C. · CIK 0001472042 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,315,416 F22 · price: Reflects a weighted average purchase price of $5.7555 per share, at prices ranging from $5.75 to $5.77 per share. F33 · price: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. F1 · ownership.nature: This statement is being filed by The Goldman Sachs Group, Inc. ("GS Group"), Goldman, Sachs & Co. ("Goldman Sachs") and GSUIG, L.L.C. ("GSUIG", and together with GS Group and Goldman Sachs, the "Reporting Persons"). Goldman Sachs is a wholly-owned subsidiary of GS Group. GS Group is the sole member of GSUIG and Goldman Sachs serves as the investment manager for GSUIG. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein. F2 · ownership.nature: Due to an inadvertent error that resulted in the Common Stock underlying the shares of convertible preferred stock of the Company held in escrow being excluded from the beneficial ownership of the Reporting Persons under Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder ("Section 13(d)"), the Reporting Persons ceased to be greater than 10% beneficial owners under Section 13(d) on August 9, 2012 (the "10% Cessation Date"), and not on June 19, 2012 as previously reported. This Form 4 filing reports transactions executed up to and including the 10% Cessation Date. The Reporting Persons have remitted to the Issuer any profits, accordingly. F3 · ownership.nature: The shares of common stock, par value $0.01 per share (the "Common Stock") of AMN Healthcare Services, Inc. (the "Company") reported herein as indirectly purchased and sold were beneficially owned directly by Goldman Sachs or GSUIG, and indirectly by GS Group. F4 · ownership.nature: As of August 9, 2012, Goldman Sachs beneficially owns directly, and GS Group may be deemed to beneficially own indirectly, 56,156 shares of Common Stock and Goldman Sachs also holds open short positions of 317,345 shares of Common Stock, reflecting changes due to exempt transactions. As of August 9, 2012, Goldman Sachs and GS Group may be deemed to beneficially own indirectly 812,175 shares of Common Stock by reason of the direct beneficial ownership of such shares by GSUIG. GS Group also beneficially owns directly 4,577 shares of Common Stock. F22 · ownership.nature: Reflects a weighted average purchase price of $5.7555 per share, at prices ranging from $5.75 to $5.77 per share. F33 · ownership.nature: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| July 31, 2012 Filed Oct 15, 2012 23:04 UTC |
GOLDMAN SACHS GROUP INC10% owner
GOLDMAN SACHS & CO. LLC10% owner
GSUIG, L.L.C.10% owner
|
SaleCommon Stock | 18,314 | $5.89 | $107,869.46 |
DisclosureSEC source: 0000769993-12-000566 · ownershipdoc09062012120835.xml · nonDerivative · entry 17 GOLDMAN SACHS GROUP INC · CIK 0000886982 · 10% owner GOLDMAN SACHS & CO · CIK 0000769993 · 10% owner GSUIG, L.L.C. · CIK 0001472042 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,314,486 F21 · price: Reflects a weighted average sale price of $5.89 per share, at prices ranging from $5.825 to $6.03 per share. F33 · price: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. F1 · ownership.nature: This statement is being filed by The Goldman Sachs Group, Inc. ("GS Group"), Goldman, Sachs & Co. ("Goldman Sachs") and GSUIG, L.L.C. ("GSUIG", and together with GS Group and Goldman Sachs, the "Reporting Persons"). Goldman Sachs is a wholly-owned subsidiary of GS Group. GS Group is the sole member of GSUIG and Goldman Sachs serves as the investment manager for GSUIG. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein. F2 · ownership.nature: Due to an inadvertent error that resulted in the Common Stock underlying the shares of convertible preferred stock of the Company held in escrow being excluded from the beneficial ownership of the Reporting Persons under Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder ("Section 13(d)"), the Reporting Persons ceased to be greater than 10% beneficial owners under Section 13(d) on August 9, 2012 (the "10% Cessation Date"), and not on June 19, 2012 as previously reported. This Form 4 filing reports transactions executed up to and including the 10% Cessation Date. The Reporting Persons have remitted to the Issuer any profits, accordingly. F3 · ownership.nature: The shares of common stock, par value $0.01 per share (the "Common Stock") of AMN Healthcare Services, Inc. (the "Company") reported herein as indirectly purchased and sold were beneficially owned directly by Goldman Sachs or GSUIG, and indirectly by GS Group. F4 · ownership.nature: As of August 9, 2012, Goldman Sachs beneficially owns directly, and GS Group may be deemed to beneficially own indirectly, 56,156 shares of Common Stock and Goldman Sachs also holds open short positions of 317,345 shares of Common Stock, reflecting changes due to exempt transactions. As of August 9, 2012, Goldman Sachs and GS Group may be deemed to beneficially own indirectly 812,175 shares of Common Stock by reason of the direct beneficial ownership of such shares by GSUIG. GS Group also beneficially owns directly 4,577 shares of Common Stock. F21 · ownership.nature: Reflects a weighted average sale price of $5.89 per share, at prices ranging from $5.825 to $6.03 per share. F33 · ownership.nature: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| July 31, 2012 Filed Oct 15, 2012 23:04 UTC |
GOLDMAN SACHS GROUP INC10% owner
GOLDMAN SACHS & CO. LLC10% owner
GSUIG, L.L.C.10% owner
|
PurchaseCommon Stock | 4,035 | $5.86 | $23,643.89 |
DisclosureSEC source: 0000769993-12-000566 · ownershipdoc09062012120835.xml · nonDerivative · entry 16 GOLDMAN SACHS GROUP INC · CIK 0000886982 · 10% owner GOLDMAN SACHS & CO · CIK 0000769993 · 10% owner GSUIG, L.L.C. · CIK 0001472042 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,332,800 F20 · price: Reflects a weighted average purchase price of $5.8597 per share, at prices ranging from $5.83 to $5.90 per share. F33 · price: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. F1 · ownership.nature: This statement is being filed by The Goldman Sachs Group, Inc. ("GS Group"), Goldman, Sachs & Co. ("Goldman Sachs") and GSUIG, L.L.C. ("GSUIG", and together with GS Group and Goldman Sachs, the "Reporting Persons"). Goldman Sachs is a wholly-owned subsidiary of GS Group. GS Group is the sole member of GSUIG and Goldman Sachs serves as the investment manager for GSUIG. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein. F2 · ownership.nature: Due to an inadvertent error that resulted in the Common Stock underlying the shares of convertible preferred stock of the Company held in escrow being excluded from the beneficial ownership of the Reporting Persons under Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder ("Section 13(d)"), the Reporting Persons ceased to be greater than 10% beneficial owners under Section 13(d) on August 9, 2012 (the "10% Cessation Date"), and not on June 19, 2012 as previously reported. This Form 4 filing reports transactions executed up to and including the 10% Cessation Date. The Reporting Persons have remitted to the Issuer any profits, accordingly. F3 · ownership.nature: The shares of common stock, par value $0.01 per share (the "Common Stock") of AMN Healthcare Services, Inc. (the "Company") reported herein as indirectly purchased and sold were beneficially owned directly by Goldman Sachs or GSUIG, and indirectly by GS Group. F4 · ownership.nature: As of August 9, 2012, Goldman Sachs beneficially owns directly, and GS Group may be deemed to beneficially own indirectly, 56,156 shares of Common Stock and Goldman Sachs also holds open short positions of 317,345 shares of Common Stock, reflecting changes due to exempt transactions. As of August 9, 2012, Goldman Sachs and GS Group may be deemed to beneficially own indirectly 812,175 shares of Common Stock by reason of the direct beneficial ownership of such shares by GSUIG. GS Group also beneficially owns directly 4,577 shares of Common Stock. F20 · ownership.nature: Reflects a weighted average purchase price of $5.8597 per share, at prices ranging from $5.83 to $5.90 per share. F33 · ownership.nature: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| July 30, 2012 Filed Oct 15, 2012 23:04 UTC |
GOLDMAN SACHS GROUP INC10% owner
GOLDMAN SACHS & CO. LLC10% owner
GSUIG, L.L.C.10% owner
|
SaleCommon Stock | 7,786 | $6.11 | $47,605.94 |
DisclosureSEC source: 0000769993-12-000566 · ownershipdoc09062012120835.xml · nonDerivative · entry 15 GOLDMAN SACHS GROUP INC · CIK 0000886982 · 10% owner GOLDMAN SACHS & CO · CIK 0000769993 · 10% owner GSUIG, L.L.C. · CIK 0001472042 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,328,765 F19 · price: Reflects a weighted average sale price of $6.1143 per share, at prices ranging from $6.08 to $6.22 per share. F33 · price: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. F1 · ownership.nature: This statement is being filed by The Goldman Sachs Group, Inc. ("GS Group"), Goldman, Sachs & Co. ("Goldman Sachs") and GSUIG, L.L.C. ("GSUIG", and together with GS Group and Goldman Sachs, the "Reporting Persons"). Goldman Sachs is a wholly-owned subsidiary of GS Group. GS Group is the sole member of GSUIG and Goldman Sachs serves as the investment manager for GSUIG. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein. F2 · ownership.nature: Due to an inadvertent error that resulted in the Common Stock underlying the shares of convertible preferred stock of the Company held in escrow being excluded from the beneficial ownership of the Reporting Persons under Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder ("Section 13(d)"), the Reporting Persons ceased to be greater than 10% beneficial owners under Section 13(d) on August 9, 2012 (the "10% Cessation Date"), and not on June 19, 2012 as previously reported. This Form 4 filing reports transactions executed up to and including the 10% Cessation Date. The Reporting Persons have remitted to the Issuer any profits, accordingly. F3 · ownership.nature: The shares of common stock, par value $0.01 per share (the "Common Stock") of AMN Healthcare Services, Inc. (the "Company") reported herein as indirectly purchased and sold were beneficially owned directly by Goldman Sachs or GSUIG, and indirectly by GS Group. F4 · ownership.nature: As of August 9, 2012, Goldman Sachs beneficially owns directly, and GS Group may be deemed to beneficially own indirectly, 56,156 shares of Common Stock and Goldman Sachs also holds open short positions of 317,345 shares of Common Stock, reflecting changes due to exempt transactions. As of August 9, 2012, Goldman Sachs and GS Group may be deemed to beneficially own indirectly 812,175 shares of Common Stock by reason of the direct beneficial ownership of such shares by GSUIG. GS Group also beneficially owns directly 4,577 shares of Common Stock. F19 · ownership.nature: Reflects a weighted average sale price of $6.1143 per share, at prices ranging from $6.08 to $6.22 per share. F33 · ownership.nature: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| July 30, 2012 Filed Oct 15, 2012 23:04 UTC |
GOLDMAN SACHS GROUP INC10% owner
GOLDMAN SACHS & CO. LLC10% owner
GSUIG, L.L.C.10% owner
|
PurchaseCommon Stock | 3,346 | $6.08 | $20,347.03 |
DisclosureSEC source: 0000769993-12-000566 · ownershipdoc09062012120835.xml · nonDerivative · entry 14 GOLDMAN SACHS GROUP INC · CIK 0000886982 · 10% owner GOLDMAN SACHS & CO · CIK 0000769993 · 10% owner GSUIG, L.L.C. · CIK 0001472042 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,336,551 F18 · price: Reflects a weighted average purchase price of $6.081 per share, at prices ranging from $6.03 to $6.18 per share. F33 · price: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. F1 · ownership.nature: This statement is being filed by The Goldman Sachs Group, Inc. ("GS Group"), Goldman, Sachs & Co. ("Goldman Sachs") and GSUIG, L.L.C. ("GSUIG", and together with GS Group and Goldman Sachs, the "Reporting Persons"). Goldman Sachs is a wholly-owned subsidiary of GS Group. GS Group is the sole member of GSUIG and Goldman Sachs serves as the investment manager for GSUIG. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein. F2 · ownership.nature: Due to an inadvertent error that resulted in the Common Stock underlying the shares of convertible preferred stock of the Company held in escrow being excluded from the beneficial ownership of the Reporting Persons under Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder ("Section 13(d)"), the Reporting Persons ceased to be greater than 10% beneficial owners under Section 13(d) on August 9, 2012 (the "10% Cessation Date"), and not on June 19, 2012 as previously reported. This Form 4 filing reports transactions executed up to and including the 10% Cessation Date. The Reporting Persons have remitted to the Issuer any profits, accordingly. F3 · ownership.nature: The shares of common stock, par value $0.01 per share (the "Common Stock") of AMN Healthcare Services, Inc. (the "Company") reported herein as indirectly purchased and sold were beneficially owned directly by Goldman Sachs or GSUIG, and indirectly by GS Group. F4 · ownership.nature: As of August 9, 2012, Goldman Sachs beneficially owns directly, and GS Group may be deemed to beneficially own indirectly, 56,156 shares of Common Stock and Goldman Sachs also holds open short positions of 317,345 shares of Common Stock, reflecting changes due to exempt transactions. As of August 9, 2012, Goldman Sachs and GS Group may be deemed to beneficially own indirectly 812,175 shares of Common Stock by reason of the direct beneficial ownership of such shares by GSUIG. GS Group also beneficially owns directly 4,577 shares of Common Stock. F18 · ownership.nature: Reflects a weighted average purchase price of $6.081 per share, at prices ranging from $6.03 to $6.18 per share. F33 · ownership.nature: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| July 27, 2012 Filed Oct 15, 2012 23:04 UTC |
GOLDMAN SACHS GROUP INC10% owner
GOLDMAN SACHS & CO. LLC10% owner
GSUIG, L.L.C.10% owner
|
SaleCommon Stock | 37,073 | $6.12 | $226,912.71 |
DisclosureSEC source: 0000769993-12-000566 · ownershipdoc09062012120835.xml · nonDerivative · entry 13 GOLDMAN SACHS GROUP INC · CIK 0000886982 · 10% owner GOLDMAN SACHS & CO · CIK 0000769993 · 10% owner GSUIG, L.L.C. · CIK 0001472042 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,333,205 F17 · price: Reflects a weighted average sale price of $6.1207 per share, at prices ranging from $6.02 to $6.16 per share. F33 · price: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. F1 · ownership.nature: This statement is being filed by The Goldman Sachs Group, Inc. ("GS Group"), Goldman, Sachs & Co. ("Goldman Sachs") and GSUIG, L.L.C. ("GSUIG", and together with GS Group and Goldman Sachs, the "Reporting Persons"). Goldman Sachs is a wholly-owned subsidiary of GS Group. GS Group is the sole member of GSUIG and Goldman Sachs serves as the investment manager for GSUIG. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein. F2 · ownership.nature: Due to an inadvertent error that resulted in the Common Stock underlying the shares of convertible preferred stock of the Company held in escrow being excluded from the beneficial ownership of the Reporting Persons under Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder ("Section 13(d)"), the Reporting Persons ceased to be greater than 10% beneficial owners under Section 13(d) on August 9, 2012 (the "10% Cessation Date"), and not on June 19, 2012 as previously reported. This Form 4 filing reports transactions executed up to and including the 10% Cessation Date. The Reporting Persons have remitted to the Issuer any profits, accordingly. F3 · ownership.nature: The shares of common stock, par value $0.01 per share (the "Common Stock") of AMN Healthcare Services, Inc. (the "Company") reported herein as indirectly purchased and sold were beneficially owned directly by Goldman Sachs or GSUIG, and indirectly by GS Group. F4 · ownership.nature: As of August 9, 2012, Goldman Sachs beneficially owns directly, and GS Group may be deemed to beneficially own indirectly, 56,156 shares of Common Stock and Goldman Sachs also holds open short positions of 317,345 shares of Common Stock, reflecting changes due to exempt transactions. As of August 9, 2012, Goldman Sachs and GS Group may be deemed to beneficially own indirectly 812,175 shares of Common Stock by reason of the direct beneficial ownership of such shares by GSUIG. GS Group also beneficially owns directly 4,577 shares of Common Stock. F17 · ownership.nature: Reflects a weighted average sale price of $6.1207 per share, at prices ranging from $6.02 to $6.16 per share. F33 · ownership.nature: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| July 27, 2012 Filed Oct 15, 2012 23:04 UTC |
GOLDMAN SACHS GROUP INC10% owner
GOLDMAN SACHS & CO. LLC10% owner
GSUIG, L.L.C.10% owner
|
PurchaseCommon Stock | 4,110 | $6.11 | $25,119.91 |
DisclosureSEC source: 0000769993-12-000566 · ownershipdoc09062012120835.xml · nonDerivative · entry 12 GOLDMAN SACHS GROUP INC · CIK 0000886982 · 10% owner GOLDMAN SACHS & CO · CIK 0000769993 · 10% owner GSUIG, L.L.C. · CIK 0001472042 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,370,278 F16 · price: Reflects a weighted average purchase price of $6.1119 per share, at prices ranging from $5.98 to $6.15 per share. F33 · price: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. F1 · ownership.nature: This statement is being filed by The Goldman Sachs Group, Inc. ("GS Group"), Goldman, Sachs & Co. ("Goldman Sachs") and GSUIG, L.L.C. ("GSUIG", and together with GS Group and Goldman Sachs, the "Reporting Persons"). Goldman Sachs is a wholly-owned subsidiary of GS Group. GS Group is the sole member of GSUIG and Goldman Sachs serves as the investment manager for GSUIG. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein. F2 · ownership.nature: Due to an inadvertent error that resulted in the Common Stock underlying the shares of convertible preferred stock of the Company held in escrow being excluded from the beneficial ownership of the Reporting Persons under Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder ("Section 13(d)"), the Reporting Persons ceased to be greater than 10% beneficial owners under Section 13(d) on August 9, 2012 (the "10% Cessation Date"), and not on June 19, 2012 as previously reported. This Form 4 filing reports transactions executed up to and including the 10% Cessation Date. The Reporting Persons have remitted to the Issuer any profits, accordingly. F3 · ownership.nature: The shares of common stock, par value $0.01 per share (the "Common Stock") of AMN Healthcare Services, Inc. (the "Company") reported herein as indirectly purchased and sold were beneficially owned directly by Goldman Sachs or GSUIG, and indirectly by GS Group. F4 · ownership.nature: As of August 9, 2012, Goldman Sachs beneficially owns directly, and GS Group may be deemed to beneficially own indirectly, 56,156 shares of Common Stock and Goldman Sachs also holds open short positions of 317,345 shares of Common Stock, reflecting changes due to exempt transactions. As of August 9, 2012, Goldman Sachs and GS Group may be deemed to beneficially own indirectly 812,175 shares of Common Stock by reason of the direct beneficial ownership of such shares by GSUIG. GS Group also beneficially owns directly 4,577 shares of Common Stock. F16 · ownership.nature: Reflects a weighted average purchase price of $6.1119 per share, at prices ranging from $5.98 to $6.15 per share. F33 · ownership.nature: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| July 26, 2012 Filed Oct 15, 2012 23:04 UTC |
GOLDMAN SACHS GROUP INC10% owner
GOLDMAN SACHS & CO. LLC10% owner
GSUIG, L.L.C.10% owner
|
SaleCommon Stock | 15,068 | $5.95 | $89,645.56 |
DisclosureSEC source: 0000769993-12-000566 · ownershipdoc09062012120835.xml · nonDerivative · entry 11 GOLDMAN SACHS GROUP INC · CIK 0000886982 · 10% owner GOLDMAN SACHS & CO · CIK 0000769993 · 10% owner GSUIG, L.L.C. · CIK 0001472042 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,366,168 F15 · price: Reflects a weighted average sale price of $5.9494 per share, at prices ranging from $5.90 to $6.05 per share. F33 · price: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. F1 · ownership.nature: This statement is being filed by The Goldman Sachs Group, Inc. ("GS Group"), Goldman, Sachs & Co. ("Goldman Sachs") and GSUIG, L.L.C. ("GSUIG", and together with GS Group and Goldman Sachs, the "Reporting Persons"). Goldman Sachs is a wholly-owned subsidiary of GS Group. GS Group is the sole member of GSUIG and Goldman Sachs serves as the investment manager for GSUIG. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein. F2 · ownership.nature: Due to an inadvertent error that resulted in the Common Stock underlying the shares of convertible preferred stock of the Company held in escrow being excluded from the beneficial ownership of the Reporting Persons under Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder ("Section 13(d)"), the Reporting Persons ceased to be greater than 10% beneficial owners under Section 13(d) on August 9, 2012 (the "10% Cessation Date"), and not on June 19, 2012 as previously reported. This Form 4 filing reports transactions executed up to and including the 10% Cessation Date. The Reporting Persons have remitted to the Issuer any profits, accordingly. F3 · ownership.nature: The shares of common stock, par value $0.01 per share (the "Common Stock") of AMN Healthcare Services, Inc. (the "Company") reported herein as indirectly purchased and sold were beneficially owned directly by Goldman Sachs or GSUIG, and indirectly by GS Group. F4 · ownership.nature: As of August 9, 2012, Goldman Sachs beneficially owns directly, and GS Group may be deemed to beneficially own indirectly, 56,156 shares of Common Stock and Goldman Sachs also holds open short positions of 317,345 shares of Common Stock, reflecting changes due to exempt transactions. As of August 9, 2012, Goldman Sachs and GS Group may be deemed to beneficially own indirectly 812,175 shares of Common Stock by reason of the direct beneficial ownership of such shares by GSUIG. GS Group also beneficially owns directly 4,577 shares of Common Stock. F15 · ownership.nature: Reflects a weighted average sale price of $5.9494 per share, at prices ranging from $5.90 to $6.05 per share. F33 · ownership.nature: Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.